Henry habló por teléfono con Blatter tras la polémica mano contra Irlanda

November 30, 2009 | In: General

JOHANNESBURGO (AFP) – El presidente de la Federación Internacional de Fútbol (FIFA), Joseph Blatter, dijo este lunes que habló por teléfono con el francés Thierry Henry después de la mano cometida por éste ante Irlanda para asistir a Gallas en el gol que permitió la clasificación de Francia para el Mundial-2010.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.

OSLO (AFP) – - El premio Nobel de la Paz fue atribuido este viernes al presidente estadounidense Barack Obama, el primer negro en llegar a la Casa Blanca, quien dio un giro radical a la política exterior de su país optando por una estrategia más consensual y multilateral.

The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine.

The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.

BERLÍN (AFP) – - La canciller alemana conservadora Angela Merkel logró un segundo mandato en las elecciones legislativas de su país este domingo y podría formar gobierno de centro-derecha con los liberales, según encuestas a boca de urna.

The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units.

BRUSELAS (AFP) – Europa aprobó el jueves un plan de ayuda a la endeudada Grecia, que incluye por primera vez la implicación del FMI en la crisis de un país de la Eurozona, como pedía Alemania, que además hizo prometer a sus socios que se endurecerá la política sobre disciplina presupuestaria.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment.

With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies.

Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys.

What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation. For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering. Barr Pharmaceuticals is one of the USA’s leading generic manufacturers. Thecompany has a policy of early market entry for generics, and as such isgenerally involved in a large amount of litigation.

BERLIN (AFP) – Los pilotos de la primera compañía aérea alemana, Lufthansa, comenzaron la noche del domingo al lunes una huelga que debe prolongarse hasta el jueves, un movimiento laboral calificado como el más importante en la historia del transporte aéreo alemán.

In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation.

For more information visit http:// WoodSenior Fax from USA: 646-607-1907Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Barr Pharmaceuticals Generics CompanyIntelligence Report” company profile to their offering. Barr Pharmaceuticals is one of the USA’s leading generic manufacturers. Thecompany has a policy of early market entry for generics, and as such isgenerally involved in a large amount of litigation. Sales also tend to fluctuateyear on year, as specific exclusivities are gained and expire. Fluoxetine andciprofloxacin are notable examples in recent years. In June 2006, Barr’s offer to acquire Pliva was accepted by the board of theCroatian company.

Es kann sein, dass eine Wiederaufnahme der Anti-Hepatitis B-Therapieangezeigt ist. Bei Patienten mitNierenbeeinträchtigung sollte das Dosierungsintervall von Vireal angepasstwerden. Bei der Verwendung von Nukleosid-Analoga einschließlich Viread wurde von Fällenvon Milchsäureakzidose und schwerer Hepatomegalie mit Steatose einschließlichTodesfällen berichtet. Bei HBV-infizierten Patienten, die die Anti-Hepatitis B-Therapie einschließlichViread abgesetzt haben, wurde von Fällen schwerer akuter Verschlimmerung derHepatitis berichtet. Die Leberfunktion sollte bei Patienten, die dieAnti-Hepatitis B-Therapie einschließlich Viread abgesetzt haben, mindestensmehrere Monate lang mit sowohl klinischer als auch Labornachsorge überwachtwerden.

Viread ist auch zur Behandlung von chronischer Hepatitis Bbei Erwachsenen angezeigt. Als empfohlene Dosis für die Behandlung von HIV sind 300 mg einmal täglichunabhängig von Mahlzeiten oral einzunehmen. Erik DeClercq, Rega-Institut für Medizinische Forschung, KatholischeUniversität in Leuven, Belgien, entdeckt. Die Erfinder haben zugestimmt, auf ihrRecht auf Tantiemen am Verkauf von Produkten, die Tenofivir enthalten, inEntwicklungsländern mit niedrigem Einkommen zu verzichten, die vom Gilead AccessProgram bedient werden. Über VireadIn den Vereinigten Staaten ist Viread® (Tenofovirdisoproxilfumarat) inKombination mit anderen antiretroviralen Mitteln für die Behandlung einerHIV-1-Infektion angezeigt. Die folgenden Punkte sind zu beachten, wenn eineTherapie mit Viread zur Behandlung von HIV-1 begonnen wird: Viread sollte nichtin Kombination mit Truvada® (Emtricitabin und Tenofovirdisoproxilfumarat) oderAtripla® (Efavirenz 600 mg/Emtricitabin 200 mg/Tenofovirdisoproxilfumarat 300mg) verwendet werden. Antonin Holy, Institut für Organische Chemie und Biochemie,Naturwissenschaftliche Akademie der Tschechischen Republik (IOB) in Prag, undDr.

Außerdem bietet Gilead mit einem gestuften Preissystem in etwa 130Ländern mit niedrigem und mittlerem Einkommen wesentliche Preissenkungen an.Gegenwärtig erhalten über 500.000 Patienten in den Entwicklungsländern Vireadoder Truvada. Die Stammverbindung von Viread wurde durch eine gemeinsame Forschungsbestrebungvon Dr. Das Unternehmen hat zahlreiche Partnerschaften mit Herstellern vonGenerika in Indien hergestellt, um hochqualitative günstige Generikaversionenseiner Antiretroviralmedikamente herzustellen und in 95 Entwicklungsländern zuvertreiben. Viread und Truvada® (Emtricitabin und Tenofovirdisoproxilfumarat) werden in denHIV-Behandlungsrichtlinien der World Health Organization (WHO) als First Lineund Second Line antiretrovirale Optionen für die Entwicklungsländer empfohlen.Gilead engagiert sich für die Erweiterung des weltweiten Zugriffs auf dieseMedikamente. Die meisten dieser Fälleumfassten auch andere mit HIV verbundene Krankheiten.

Nur zwei Todesfällestanden eindeutig oder wahrscheinlich im Zusammenhang mit der antiretroviralenTherapie, unter anderem mit Viread. Drei andere Todesfälle ereigneten sich beiPatienten, die zu Beginn der Studie eine schwerwiegend gesenkte GFR hatten undalle Viread als Teil ihrer Behandlungstherapie erhielten. Unabhängig davon, ob die Patienten Labortests durchliefen, undunabhängig von den Behandlungstherapien der Patienten traten schwerwiegendeAbfälle der GFR oder CNV bei den DART-Teilnehmern selten auf Nierenversagen trug zu 16 Todesfällen während DART bei. Abhängig vomverwendeten Kriterium litten entweder 3,4 Prozent oder 5,9 Prozent derPatienten, die Viread erhielten, während der Studie an CNV, im Vergleich zu 2,1oder 3,1 Prozent von Patienten, die eine Behandlung mit Abacavir erhielten, und1,1 Prozent oder 2,1 Prozent der Patienten, die eine Behandlung mit Nevirapinerhielten. Eine CNV war etwas häufigerbei Patienten, die eine Behandlung mit Viread erhielten. Ein schwerer GFR-Abfall wurde bei 3,1 Prozent der Teilnehmerin Behandlung mit Viread beobachtet, verglichen mit 2,4 Prozent und 1,9 Prozentder Patienten, die eine Studienbehandlung mit jeweils Abacavir und Nevirapinerhielten, was statistisch nicht signifikant war.

TOKIO (AFP) – El Gobierno japonés adoptó este martes un nuevo gran plan de reactivación, por 274.000 millones de dólares (184.000 millones de euros), para sostener a la segunda economía mundial en su lucha contra la deflación y la amenaza siempre vigente de volver a caer en una recesión.

GAZA (AFP) – Dos miembros del brazo armado de Hamas murieron el lunes por la noche en una explosión en un barrio de Gaza, informaron médicos y testigos.

SAO PAULO (AFP) – El astro brasileño Ronaldo, de 33 años y al servicio del club Corinthians de Sao Paulo, anunció este lunes que pondrá fin a su carrera profesional como futbolista a fines de 2011.

In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys. What many filmgoers don’t know is that these greatartistic achievements were made possible by Pixar’s ability to create a climatethat fosters innovation.

MIAMI (AFP) – La estrella de la música latina Chayanne tiene listo su nuevo álbum, ‘Nada es Imposible’, que lanzará al mercado en febrero y con el que afirma busca dar “un mensaje positivo” ante las tragedias naturales y problemas económicos que vive hoy el mundo, dijo en diálogo con AFP.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.

Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions.

Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext.

KABUL (AFP) – Un total de 17 insurgentes fueron abatidos el sábado por el Ejército afgano y bombardeos aéreos de la OTAN durante unos “violentos combates” al sur de Afganistán, anunció este domingo el Ministerio de Defensa afgano.

KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.

For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH.

All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks | Media | China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported. The targetting of Google illustrates the difficulties facedby foreign Internet firms doing business in the world’s largestonline market while avoiding charges of censorship. In an emailed statement, Google said it met with governmentofficials to discuss the problem of “pornographic content andmaterial that is harmful to children on the web in China”. “We are undertaking a thorough review of our service andtaking all necessary steps to fix any problems with ourresults. We believe we have addressed a large majority of theproblem results,” the statement said.

MADRID (AFP) – El alemán Linus Gerdemann (Milram) ganó este martes el Trofeo Inca, tercera prueba ciclista de la XIX Challenge a Mallorca, que se disputó desde la localidad de Inca a lo largo de 157,2 km.

Shares in PKN rose 2.2 percent late in the session, in linewith the wider market. The stock has gained 9.4 percent so farthis year, outperforming a 7.7 percent rise of Warsaw’s mainWIG20 index .WIG20 (Editing by David Jones). BEIJING, June 19 /PRNewswire-Asia/ — Sinovac Biotech Ltd.(NYSE Amex: SVA), a leading developer and provider of vaccines in China,announced today that the Company received the first order in China to supplyits influenza A (H1N1) vaccine to the Beijing government. The initial orderconsists of 4 million doses and is expected to be delivered by the end ofSeptember.This order will be administered to 2 million people in the highrisk group.Additional orders are expected beginning in October and, intotal,Sinovac expects to supply approximately 10 million doses to the Beijinggovernment.The 10 million doses will be administered to 5 million people inBeijing.On June 14, 2009, Sinovac completed construction of the H1N1 virus seedbank necessary to produce a virus antigen and commenced production of thefirst batch of H1N1 vaccine.Sinovac expects to complete production of thefirst batch by the end of July.Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, “Weare organizing and coordinating all personnel and resources to produce theH1N1 vaccine, as we have almost completed the production of our seasonalinfluenza vaccine.With the support and instruction of the relevantgovernment and health authorities, Sinovac will fully utilize its provendevelopment and production abilities from both the H5N1 vaccine and seasonalflu vaccine to ensure the efficient production of the H1N1 vaccine.We areworking closely with authorities in order to contribute to the prevention andcontrol of the H1N1 epidemic situation.”About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases. Sinovac’s vaccineproducts include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A andB), and Anflu(R) (influenza).

Panflu(TM), Sinovac’s pandemic influenza vaccine(H5N1), has already been approved for government stockpiling.Sinovac isdeveloping vaccines for enterovirus 71, universal pandemic influenza, Japaneseencephalitis vaccine, and human rabies vaccine.Its wholly owned subsidiary,Tangshan Yian, is conducting field trials for independently developedinactivated animal rabies vaccines.Safe Harbor StatementThis announcement contains forward-looking statements. These statementsare made under the “safe harbor” provisions of the U.S Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by words or phrases such as “will,” “expects,” “anticipates,”"future,” “intends,” “plans,” “believes,” “estimates” and similar statements.Among other things, the business outlook and quotations from management inthis press release contain forward-looking statements. Statements that are nothistorical facts, including statements about Sinovac’s beliefs andexpectations, are forward-looking statements. Forward-looking statementsinvolve inherent risks and uncertainties. A number of important factors couldcause actual results to differ materially from those contained in anyforward-looking statement. Sinovac does not undertake any obligation to updateany forward-looking statement, except as required under applicable law.For more information, please contact: Helen G Yang Sinovac Biotech Ltd.

KABUL (AFP) – - El anuncio con cuentagotas de los resultados parciales de la elección presidencial en Afganistán se hace con ánimo de imparcialidad, dijo este miércoles el presidente saliente Hamid Karzai, que encabeza un recuento salpicado de sospechas de fraude.

SAO PAULO (AFP) – - El piloto Jenson Button (Brawn GP), quien fuera considerado a sus 20 años como la gran esperanza de la Fórmula 1, ganó este domingo el título del Campeonato Mundial de pilotos, tras disputarse en Sao Paulo el Gran Premio de Brasil, penúltima prueba de la temporada.

PARÍS (AFP) – El tenista español Rafael Nadal cayó a la cuarta posición en la clasificación de la ATP, publicada este lunes, tras ser eliminado en el torneo de Indian Wells y cede su plaza al escocés Andy Murray, finalista del Abierto de Australia tras perder contra el número uno mundial, Roger Federer.

DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies. Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster.

SINGAPUR (AFP) – - Los precios del petróleo registraban una bajada notable este lunes en las operaciones electrónicas de Asia, donde el mercado reaccionaba a la debilidad de los mercados bursátiles y a la subida del dólar, según los corredores.

Henry habló por teléfono con Blatter tras la polémica mano contra Irlanda

Comment Form

Categories

Archives

Links

Next Articles

Featured Sponsors

July 2010
M	T	W	T	F	S	S
« Jun
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31